Prevalence of metabolic dysfunction associated fatty liver disease in people with type 1 diabetes

被引：0
|
作者：
Bellido, V. [1 ]
Amuedo, S. [1 ]
Remon-Ruiz, P. [1 ]
Roque-Cuellar, C. [1 ]
Jimenez-Sanchez, A. [1 ]
Gros-Herguido, N. [1 ]
Lopez-Gallardo, G. [1 ]
Pinar-Gutierrez, A. [1 ]
Soto-Moreno, A. [1 ]
机构：
[1] Hosp Univ Virgen Rocio, UGC Endocrinol & Nutr, Seville, Spain
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：S498 / S499
页数：2
相关论文
共 50 条
  • [31] Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease
    Su, Weitao
    Chen, Minhui
    Xiao, Ling
    Du, Shanshan
    Xue, Lihua
    Feng, Ruimei
    Ye, Weimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
    Csermely, Alessandro
    Mantovani, Alessandro
    Morieri, Mario Luca
    Palmisano, Luisa
    Masulli, Maria
    Cossu, Efisio
    Baroni, Marco Giorgio
    Bonomo, Katia
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Aldigeri, Raffaella
    Dei Cas, Alessandra
    de Kreutzenberg, Saula Vigili
    Targher, Giovanni
    DIABETES & METABOLISM, 2023, 49 (06)
  • [33] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [34] Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
    Cusi, Kenneth
    Sanyal, Arun J.
    Zhang, Shuyu
    Hartman, Mark L.
    Bue-Valleskey, Juliana M.
    Hoogwerf, Byron J.
    Haupt, Axel
    DIABETES OBESITY & METABOLISM, 2017, 19 (11): : 1630 - 1634
  • [35] The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study
    Van Nieuwenhove, T.
    Rasschaert, G.
    Kharagjitsingh, A.
    Keymeulen, B.
    Reynaert, H.
    Kindt, S.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2021, 84 (04) : 541 - 547
  • [36] Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]
    Md. Musab Khalil
    Sirajam Munira
    Md. Mahbubul Alam
    Al Mahmood Appolo
    Musatafa Md. Abu Sayeed
    Atikul Islam
    Narwana Khaleque
    Mohammad Faisal
    Arifa Tasnim
    Ruma Najnin
    Mahmudur Rahman
    Enamul Karim
    Md. Golam Kibria
    SN Comprehensive Clinical Medicine, 6 (1)
  • [37] Prevalence and associated metabolic factors of fatty liver disease in the elderly
    Wang, Zhongli
    Xu, Ming
    Peng, Jianhong
    Jiang, Li
    Hu, Zhengguo
    Wang, Hua
    Zhou, Shiqing
    Zhou, Rui
    Hultstrom, Michael
    Lai, En Yin
    EXPERIMENTAL GERONTOLOGY, 2013, 48 (08) : 705 - 709
  • [38] The Many Names of Fatty Liver Disease: Strengths and Limitations of Metabolic (Dysfunction) -Associated Fatty Liver Disease
    Czepiel, Kathryn S.
    Stanford, Fatima Cody
    CHILDHOOD OBESITY, 2023, 19 (01) : 1 - 2
  • [39] Frailty in metabolic dysfunction-associated fatty liver disease is related to the presence of diabetes and the severity of liver fibrosis
    Goffaux, Alexis
    Henin, Guillaume
    Loumaye, Audrey
    Dahlqvist, Geraldine
    Lanthier, Nicolas
    JOURNAL OF HEPATOLOGY, 2023, 78 : S639 - S640
  • [40] Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes
    Mantovani, Alessandro
    Csermely, Alessandro
    Taverna, Antonio
    Cappelli, Davide
    Benfari, Giovanni
    Bonapace, Stefano
    Byrne, Christopher D.
    Targher, Giovanni
    DIABETES & METABOLISM, 2023, 49 (02)
12345